Invited as presenter at the Immunotherapies & Innovations for Infectious Diseases Congress (#I4ID2025) – in Lyon, CEO of

Chairman Dr Sara Malcus and CEO Peter Olofsson-Sahl participated in the Nordic Life Science days. Reconnecting with several

Inicures founders and researchers Professor Johan Bylund at the University of Gothenburg, together with Dr. Peter Olofsson-Sahl at

CEO, Peter Olofsson-Sahl presented Inicure at the #BiotechHanse event as innovative Swedish Life Science innovation for Sweden-Germany collaboration

As partner to the IMPACT project led by University Southern Denmark (SDU) and professor Thomas Andersen, Inucure is

Inicure have been granted support from VINNOVA Planeringsbidrag to improve our EIC Transition proposal. Inicure is coordinating a